Research article | Open | Open Peer Review | Published:
Depression among HIV positive pregnant women in Zimbabwe: a primary health care based cross-sectional study
BMC Pregnancy and Childbirthvolume 19, Article number: 53 (2019)
Depression is a common psychiatric disorder that is highly prevalent among people living with HIV (PLWH). Depression is linked to poor adherence to anti-retroviral medication while in the peri-natal period may affect birth outcomes. Intimate partner violence (IPV) has been linked to depression. Little is known about the factors associated with depression in HIV positive pregnant women in Zimbabwe.
We carried out a cross-sectional study in 4 busy primary care clinics offering antenatal services during the months of June through to September in 2016. Simple random sampling was used to screen HIV positive pregnant women while they waited to be attended to at each clinic. Eligible women who gave written informed consent were screened using a locally validated screening tool-the Edinburgh Postnatal Depression Scale (EPDS).
A total of 198(85%) participants were recruited out of 234 that were approached. The mean age of participants was 26.6(SD 4.5), of these, 176 (88.9%) had secondary education or more. A total of 78 (39.4%) (95% CI 32.5–46.3) met criteria for antenatal depression according to the local version of the EPDS. Factors associated with antenatal depression after multivariate analysis were intimate partner violence (IPV) [OR 3.2 (95% CI 1.5–6.7)] and previous history of depression OR 4.1 (95% CI 2.0–8.0)].
The prevalence of antenatal depression among HIV positive pregnant women in primary care clinics is high. Factors associated with antenatal depression in pregnant HIV positive women are IPV and previous history of depression. There is need for routine screening for depression during the antenatal period and interventions targeting depression in this population should include components to address IPV.
Sub Saharan Africa (SSA) is the epicentre of the HIV/AIDS pandemic with over 60% of all global cases . In SSA, women constitute 59% of those living with HIV  with women of child-bearing age most affected .
Depression is highly prevalent in people living with HIV (PLWH), particularly in SSA . Untreated, depression may enhance HIV disease progression through both biological and social mechanisms [4, 5]. For instance adherence to anti-retroviral treatment (ART) among PLWH with depression has consistently been found to be poor [5,6,7] with a recent cohort study showing depression to have a dose response effect on mortality among PLWH . HIV positive women are particularly vulnerable to depression [9, 10]. In pregnancy rates of depression ranging from 12 to 30% have been reported through a number of systematic reviews [11,12,13] and regional studies [9, 14,15,16,17].
In Zimbabwe, little is known about antenatal depression . However, earlier studies on postnatal depression (PND) have shown rates ranging from 16 to 30% [19, 20] with similar rates reported in the region through a systematic review . There is evidence suggesting that PND often first manifests in the antenatal period  therefore identifying and treating pregnant women with depression may lead to better health outcomes for both mother and infant .
Evidence based interventions for PLWH affected by depression are known to improve HIV disease outcomes . Most of these interventions based on task-shifting have shown promising results in SSA, including Zimbabwe [24,25,26,27,28,29].
The aim of this study was to determine the prevalence and factors associated with depression in the antenatal period as part of a policy brief aimed at justifying the introduction of a care program for depression during the antenatal period for HIV positive pregnant women. Furthermore, based on earlier work highlighting intimate partner violence (IPV) as a factor associated with depression in women, [19, 25] we sought to establish the magnitude of IPV in pregnant HIV positive women.
We conducted a cross-sectional survey of HIV positive pregnant women attending the Chitungwiza City Council antenatal clinics outside of Harare, the capital city of Zimbabwe.
Chitungwiza is a high density suburb situated about 30 km south of Harare. It has four city council clinics which provide services to an estimated 1.2 million people. Each clinic offers general medical and surgical care, as well as maternity services provided by nurses and visiting medical doctors. All 4 clinics also offer provider initiated testing and counselling for HIV, including initiation of anti-retroviral treatment (ARV) and follow up of PLWH. Cases that cannot be managed at clinic level are referred to Chitungwiza Central Hospital which is run by specialised staff.
The maternity services offered in Chitungwiza commence during the antenatal period when pregnant women register for delivery. During registration all women are pre-test counselled, tested for HIV and are post-test counselled. Those found to be HIV positive are counselled further and initiated on ARV on the same day (Option B+).
All pregnant HIV positive women in the first trimester booked at Chitungwiza city council antenatal clinics were eligible for inclusion in the study.
Those who were HIV negative, or had an unconfirmed HIV positive result, showed psychotic symptoms, an intellectual disability or could not give informed consent were excluded from the study.
The sampling frame consisted of all antenatal clinic attendees registered as HIV positive utilising the facilities between 14 June 2016 to 14 September 2016. Each day during this period participants were approached based on a computer generated random number allocation. They were initially informed about the study and all those who gave initial verbal consent were further assessed for inclusion criteria which included age > 17 and a confirmed HIV+ test result. Those that met this criteria were then informed in detail of the study and if they still were interested written consent was sought.
The Edinburgh Postnatal Depression Scale (EPDS) was used to screen for antenatal depression in all 4 clinics by trained research assistants. The EPDS has been validated in Zimbabwe in the postnatal period and found to have good psychometric properties with sensitivity and specificity of 88 and 87% respectively. It has a Chronbach’s alpha of 0.87 at cut-off of 11/12 . The EPDS is a widely used screening tool in sub-Saharan Africa with most settings using a cut-off score of between 12 and 15 . It consists of 10 questions which ask about events in the past seven days. The last question assesses thoughts of self-harm and women who score anything other than 0 on this question need further assessment. Each response is scored from 0 to 3, with responses to questions 3, 5 to 10 reverse scored. The total score ranges between 0 and 30. Common cut-off scores for the EPDS range between 9 and 13 [9, 21, 30, 31].
Part of the study involved training research assistants (RA) in the administration of the EPDS and the socio-demographic questionnaire. This activity was carried out by the first author (EN) who also run a pilot before formal recruitment of study participants. The pilot included checking completeness of collected data, and crosschecking information with the antenatal register at each clinic for gestational age and date of HIV testing.
A questionnaire on socio-demographic characteristics was interviewer administered. It included questions about; when participant found out about their HIV positive status, history of intimate partner violence, history of childhood sexual abuse, previous episode of depression, and type of anti-retroviral treatment (ARVs) that participants were taking including duration in months of taking ARVs. We also captured significant life events in the past 3 months and the nature of the events. Previous history of depression was determined through a series of questions derived from the Diagnostic Statistical Manual (DSM)  which we had piloted in a previous study . Intimate partner violence (IPV) was defined as physical violence, forced sexual intercourse, committed by a partner in an intimate relationship . All other socio-demographic information used for this study was based on previous local studies in similar populations [18,19,20]. A two week period was used to pre-test and pilot tools by the first author EN.
The Statistical package for Social Scientist (SPSS) version 16.0 was utilised for data analysis. Continuous variable results were presented as means ± SEM. Categorical variables were expressed as percentages and frequencies, and compared using the Chi-square test to compute p-values. Binary logistic regression was used to find significant predictors of depression and also to estimate odds ratios and 95% confidence intervals for the risk factors. All statistical significance was evaluated at p < 0.05 (2 sided). A logistic regression analysis was conducted to predict depression among HIV positive mothers of 198 participants using the variables in the table (Table 1). A test of the full model against a constant only model was carried out to determine significance and to indicate that the predictors as a set reliably distinguished between those who were depressed and non-depressed. Nagelkerke’s R2 was measured to determine strength of relationship.
Furthermore, during analysis where there was no pattern in missing data on any variables these responses were omitted.
Ethical approval was sought from the Joint Research Ethical Committee (JREC), Chitungwiza City Council Department of Health and the Medical Research Council of Zimbabwe (MRCZ). Written informed consent was obtained from everyone who agreed to participate in the study. Interviews were held in private consultation rooms for privacy. To maintain confidentiality, study participants were identified using study participant numbers.
Only a few people had access to the study material of study participants, that is: the first author, last author and 2 research assistants involved in entering the data into a desktop computer.
Research material was kept locked in a safe in the department of Psychiatry. Those who were found to be severely depressed or suicidal were referred to a visiting Psychiatrist at Chitungwiza Central Hospital.
A total of 234 women were randomly approached with 198 (85%) of them giving written informed consent to participate in the study. From the 198 women, 78 (39.4%), 95% CI 32.5–46.3 met depression criteria according to the EPDS using the local cut-off score of 12 > . Most of the participants (58%) were aged between 25 and 34 years with the mean age being 26.6 (SD4.5). There was no statistically significant association between age and antenatal depression. One hundred and ninety-four (98%) of all participants were taking anti-retroviral medication (ARVs). A total of 45 (22.7%) participants reported intimate partner violence (IPV) (Table 1).
Univariate analysis showed significant odds ratios (OR) for IPV [OR 3.8 (95% CI 1.97–3.8)], childhood sexual abuse (CSA) [OR2.5 (95% CI 1.1–5.5)] and previous history of depression [OR4.8. 95% CI 2.5–9.3)], however, on multi-variate analysis IPV [OR3.2 95% CI 1.5–6.7)] and history of depression [OR 4.1 95% CI 2.0–8.0)] were the only two variables that were statistically significant Table 2.
This study carried out in 4 busy primary health care facilities in Zimbabwe showed high rates for antenatal depression (39.4%) as measured by the EPDS with IPV and previous history of depression being associated with the condition. These findings are consistent with an earlier systematic review showing that depression is common in pregnant HIV positive women and predicts non-adherence to ART treatment . Our earlier work using the Shona Symptom Questionnaire (SSQ-14)  in Zimbabwe revealed a prevalence of 19% among HIV negative women . We are not aware of other studies that have looked at the antenatal period among HIV positive pregnant women in the country. However, the prevalence of PND in a population of women attending the 6 -week post-natal clinic visit was found to be 17% using the SSQ-14  and 33%  using the validated EPDS  but both these studies had mixed populations consisting of HIV positive and negative women with varying socio-demographic characteristics. Pregnant women are at an increased risk of new onset depression [3, 17] and our findings reflect those of earlier studies carried out in the region. In Uganda a rate of 39% for depression among pregnant women was found using the Hopkins Symptoms Checklist as a screening tool , while a prevalence of 48.7% among HIV infected women in rural South Africa was reported using the EPDS at a cut-off point of 13 . In Ethiopia, using the EPDS the prevalence of antenatal depression was found to be 24.94% , while in Zambia, 85% of HIV positive pregnant women met criteria for depression . Rates described above are largely based on screening tools which invariably give varying rates based on psychometric properties of the tools. A study from South Africa found rates of 47% for depression using clinical examination based on a gold standard- The Diagnostic Statistical Manual (DSMIV) , suggesting that rates are generally high in the region. Identifying women at risk of antenatal depression early during pregnancy is therefore important in order to facilitate early referral to evidence based care programs . Depression during pregnancy can be associated with obstetric complications and is known to increase risk of poor infant outcomes such as delayed developmental milestones [17, 37] therefore early detection of affected women is critical. Our findings indicate that Intimate partner violence (IPV) is highly prevalent among pregnant women. This reflects the growing concern in low and middle income countries (LMIC) showing that an estimated 60% of women in Africa are affected by IPV which is closely linked to depression . A recent systematic review from LMIC on IPV and perinatal mental disorders during pregnancy revealed that participants who had experienced IPV had a 1.69–3.76 and 1.46–7.04 higher odds of antenatal and postnatal depression compared to those who had no IPV . The prevalence of physical IPV has been found to be as high as 35% while sexual IPV and psychological IPV were as high as 40 and 65% respectively . In Zimbabwe, a recent cluster randomised controlled trial of a brief psychological intervention delivered by lay health workers for common mental disorders (CMD) which include depression recorded IPV (physical violence) in 70.1% of those recruited . Similar findings have been reported in India . There is need to develop interventions that take into consideration IPV in women with depression.
Recently, collaborative care interventions have been found to be effective for treating depressed women in non-mental health settings . Furthermore there is growing evidence supporting the use of non-professionals who are trained and supervised to treat depression at primary health care level . Both brief and long form screening tools for depression have been found to be effective in LMIC and can be used by lay health workers (LHWs) as effective ways of identifying women at risk , with evidence suggesting that in illiterate populations visual screens could be an effective alternative for identifying those in need of care for depression .
In Zimbabwe, the scaling up of an evidence based collaborative care model for depression-the Friendship bench  has resulted in improved access to care for CMD at PHC level using trained LHWs who provide a problem solving therapy (PST) treatment  for those identified with CMD. A locally validated tool the Shona Symptom Questionnaire-14  is the main screening instrument. While the PST approach provided by the elderly LHWs has been effective , there has been no structured focus on women who report IPV during sessions on the Friendship Bench, particularly pregnant women. Furthermore, despite earlier studies showing effectiveness of group PST for women during the postnatal period , the health authorities have been slow to integrate such evidence based care packages in antenatal care services due to lack of specific evidence related to the antenatal period. The evidence provided through this study will go towards the compilation of a policy brief aimed at justifying the introduction of depression treatment during the antenatal period.
Although this study shows a high prevalence of depression among women living with HIV attending the antenatal care clinics in Zimbabwe, the use of the EPDS while convenient does have limitations: The EPDS does not provide a definitive diagnosis of depression as defined by either the DSM  or the International Classification of Disease version 10 (ICD-10)  but instead informs of the probability of an individual having depression. A clinical interview to confirm the diagnosis would provide a more accurate rate of depression. Secondly, although the EPDS is recommended for antenatal screening  it has not been validated in the antenatal period in Zimbabwe. In addition the self-reported symptoms of previous episode of depression were not validated by checking the participants medical history which introduces recall bias. Similarly, IPV did not include psychological IPV as defined by Krug .
Despite these limitations our study reflects findings similar to those from the region and beyond suggesting that depression in the antenatal period among HIV infected women is common [22, 35, 51]. It also highlights the need to focus on IPV which is a growing global problem. Using non-professionals who are trained to screen and identify those with probable depression during pregnancy and provide evidence based care management could considerably reduce the treatment gap for depression in pregnancy. A recent systematic review on IPV suggests that a problem solving therapy approach similar to that being offered by the Friendship Bench could address most issues linked to IPV . Furthermore, strengthening existing legislation aimed at preventing IPV should be prioritised by governments.
Common mental disorders
Edinburgh Post-natal depression scale
Intimate partner violence
Lay health workers
People living with HIV
Shona symptom questionnaire-14
Zachariah R, Van Damme W, Arendt V, Schmit JC, Harries AD. The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research. J Int AIDS Soc. 2011;14(Suppl 1):S7.
Chibanda D, Benjamin L, Weiss HA, Abas M. Mental, neurological, and substance use disorders in people living with HIV/AIDS in low- and middle-income countries. J Acquir Immune Defic Syndr. 2014;67(Suppl 1):S54–67.
Bonacquisti A, Geller PA, Aaron E. Rates and predictors of prenatal depression in women living with and without HIV. AIDS Care. 2014;26(1):100–6.
Antelman G, Kaaya S, Wei R, Mbwambo J, Msamanga GI, Fawzi WW, Fawzi MCS. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr. 2007;44(4):470–7.
Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.
Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47(3):259–69.
Sheth SS, Coleman J, Cannon T, Milio L, Keller J, Anderson J, Argani C. Association between depression and nonadherence to antiretroviral therapy in pregnant women with perinatally acquired HIV. AIDS Care. 2015;27(3):350–4.
Mills JC, Pence BW, Todd JV, Bengtson AM, Breger TL, Edmonds A, Cook RL, Adedimeji A, Schwartz RM, Kassaye S, et al. Cumulative burden of depression and all-cause mortality in women living with HIV. Clin Infect Dis. 2018;67(10):1575–581.
Rochat TJ, Tomlinson M, Newell ML, Stein A. Detection of antenatal depression in rural HIV-affected populations with short and ultrashort versions of the Edinburgh postnatal depression scale (EPDS). Arch Womens Ment Health. 2013;16(5):401–10.
Patel V, Araya R, de Lima M, Ludermir A, Todd C. Women, poverty and common mental disorders in four restructuring societies. Soc Sci Med. 1999;49(11):1461.
Abajobir AA, Maravilla JC, Alati R, Najman JM. A systematic review and meta-analysis of the association between unintended pregnancy and perinatal depression. J Affect Disord. 2016;192:56–63.
Grigoriadis S, VonderPorten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Radford K, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74(4):e321–41.
Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103(4):698–709.
Rochat TJ, Richter LM, Doll HA, Buthelezi NP, Tomkins A, Stein A. Depression among pregnant rural south African women undergoing HIV testing. JAMA. 2006;295(12):1376–8.
Rochat TJ, Tomlinson M, Barnighausen T, Newell ML, Stein A. The prevalence and clinical presentation of antenatal depression in rural South Africa. J Affect Disord. 2011;135(1–3):362–73.
Biratu A, Haile D. Prevalence of antenatal depression and associated factors among pregnant women in Addis Ababa, Ethiopia: a cross-sectional study. Reprod Health. 2015;12:99.
Kaida A, Matthews LT, Ashaba S, Tsai AC, Kanters S, Robak M, Psaros C, Kabakyenga J, Boum Y, Haberer JE, et al. Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr. 2014;67(Suppl 4):S179–87.
Stranix-Chibanda L, Chibanda D, Chingono A, Montgomery E, Wells J, Maldonado Y, Chipato T, Shetty AK. Screening for psychological morbidity in HIV-infected and HIV-uninfected pregnant women using community counselors in Zimbabwe. J Int Assoc Physicians AIDS Care (Chic Ill). 2005;4:83–8.
Chibanda D, Mangezi W, Tshimanga M, Woelk G, Rusakaniko S, Stranix-Chibanda L, Midzi S, Shetty AK. Postnatal depression by HIV status among women in Zimbabwe. J Women's Health (Larchmt). 2010;19(11):2071–7.
Nhiwatiwa S, Patel V, Acuda W. Predicting postnatal mental disorder with a screening questionnaire: a prospective cohort study from Zimbabwe. J Epidemiol Community Health. 1998;52(4):262–6.
Shrestha SD, Pradhan R, Tran TD, Gualano RC, Fisher JR. Reliability and validity of the Edinburgh postnatal depression scale (EPDS) for detecting perinatal common mental disorders (PCMDs) among women in low-and lower-middle-income countries: a systematic review. BMC Pregnancy Childbirth. 2016;16:72.
Psaros C, Geller PA, Aaron E. The importance of identifying and treating depression in HIV infected, pregnant women: a review. J Psychosom Obstet Gynaecol. 2009;30(4):275–81.
Chibanda D, Cowan FM, Healy JL, Abas M, Lund C. Psychological interventions for common mental disorders for people living with HIV in low- and middle-income countries: systematic review. Tropical Med Int Health. 2015;20(7):830–9.
Chibanda D, Shetty AK, Tshimanga M, Woelk G, Stranix-Chibanda L, Rusakaniko S. Group problem-solving therapy for postnatal depression among HIV-positive and HIV-negative mothers in Zimbabwe. J Int Assoc Provid AIDS Care. 2014;13(4):335–41.
Chibanda D, Weiss HA, Verhey R, Simms V, Munjoma R, Rusakaniko S, Chingono A, Munetsi E, Bere T, Manda E, et al. Effect of a primary care-based psychological intervention on symptoms of common mental disorders in Zimbabwe: a randomized clinical trial. JAMA. 2016;316(24):2618–26.
Nakimuli-Mpungu E, Okello J, Kinyanda E, Alderman S, Nakku J, Alderman JS, Pavia A, Adaku A, Allden K, Musisi S. The impact of group counseling on depression, post-traumatic stress and function outcomes: a prospective comparison study in the Peter C. Alderman trauma clinics in northern Uganda. J Affect Disord. 2013;151(1):78–84.
Kauye F, Jenkins R, Rahman A. Training primary health care workers in mental health and its impact on diagnoses of common mental disorders in primary care of a developing country, Malawi: a cluster-randomized controlled trial. Psychol Med. 2014;44(3):657–66.
Bere T, Nyamayaro P, Magidson JF, Chibanda D, Chingono A, Munjoma R, Macpherson K, Ndhlovu CE, O'Cleirigh C, Kidia K, et al. Cultural adaptation of a cognitive-behavioural intervention to improve adherence to antiretroviral therapy among people living with HIV/AIDS in Zimbabwe: Nzira Itsva. J Health Psychol. 2017;22(10):1265–76.
van't Hof E, Stein DJ, Marks I, Tomlinson M, Cuijpers P. The effectiveness of problem solving therapy in deprived south African communities: results from a pilot study. BMC Psychiatry. 2011;11(1):156.
Chibanda D, Mangezi W, Tshimanga M, Woelk G, Rusakaniko P, Stranix-Chibanda L, Midzi S, Maldonado Y, Shetty AK. Validation of the Edinburgh postnatal depression scale among women in a high HIV prevalence area in urban Zimbabwe. Arch Womens Ment Health. 2010;13(3):201–6.
Ebert DD, Buntrock C, Lehr D, Smit F, Riper H, Baumeister H, Cuijpers P, Berking M. Effectiveness of web- and Mobile-based treatment of subthreshold depression with adherence-focused guidance: a single-blind randomized controlled trial. Behav Ther. 2018;49(1):71–83.
Baarnhielm S. DSM-5 focuses on culture and context. Interview tool adapts psychiatry to the multicultural society. Lakartidningen. 2013;110(43–44):1916–7.
Donovan BM, Spracklen CN, Schweizer ML, Ryckman KK, Saftlas AF. Intimate partner violence during pregnancy and the risk for adverse infant outcomes: a systematic review and meta-analysis. BJOG. 2016;123(8):1289–99.
Patel V, Simunyu E, Gwanzura F, Lewis G, Mann A. The Shona symptom questionnaire: the development of an indigenous measure of common mental disorders in Harare. Acta Psychiatr Scand. 1997;95(6):469.
Peltzer K, Rodriguez VJ, Jones D. Prevalence of prenatal depression and associated factors among HIV-positive women in primary care in Mpumalanga province, South Africa. SAHARA J. 2016;13(1):60–7.
Kwalombota M. The effect of pregnancy in HIV-infected women. AIDS Care. 2002;14(3):431–3.
Patel V, DeSouza N, Rodrigues M. Postnatal depression and infant growth and development in low income countries: a cohort study from Goa,India. Archives of Disease in Childhood. 2003;88(1):34.
Mitchell J, Wight M, Van Heerden A, Rochat TJ. Intimate partner violence, HIV, and mental health: a triple epidemic of global proportions. Int Rev Psychiatry. 2016;28(5):452–63.
Halim N, Beard J, Mesic A, Patel A, Henderson D, Hibberd P. Intimate partner violence during pregnancy and perinatal mental disorders in low and lower middle income countries: a systematic review of literature, 1990-2017. Clin Psychol Rev. 2017.
Achchappa B, Bhandary M, Unnikrishnan B, Ramapuram JT, Kulkarni V, Rao S, Maadi D, Bhat A, Priyadarshni S. Intimate partner violence, depression, and quality of life among women living with HIV/AIDS in a Coastal City of South India. J Int Assoc Provid AIDS Care. 2017;16(5):455–9.
Huang H, Tabb KM, Cerimele JM, Ahmed N, Bhat A, Kester R. Collaborative Care for Women with Depression: a systematic review. Psychosomatics. 2017;58(1):11–8.
van Ginneken N, Tharyan P, Lewin S, Rao GN, Meera SM, Pian J, Chandrashekar S, Patel V. Non-specialist health worker interventions for the care of mental, neurological and substance-abuse disorders in low- and middle-income countries. Cochrane Database Syst Rev. 2013;11:CD009149.
Akena D, Joska J, Obuku EA, Amos T, Musisi S, Stein DJ. Comparing the accuracy of brief versus long depression screening instruments which have been validated in low and middle income countries: a systematic review. BMC Psychiatry. 2012;12(1):187.
Akena D, Joska J, Musisi S, Stein DJ. Sensitivity and specificity of a visual depression screening instrument among HIV-positive individuals in Uganda, an area with low literacy. AIDS Behav. 2012;16(8):2399–406.
Chibanda D, Verhey R, Munetsi E, Rusakaniko S, Cowan F, Lund C. Scaling up interventions for depression in sub-Saharan Africa: lessons from Zimbabwe. Global mental health. 2016;3(e13):1–9.
Chibanda D, Mesu P, Kajawu L, Cowan F, Araya R, Abas MA. Problem-solving therapy for depression and common mental disorders in Zimbabwe: piloting a task-shifting primary mental health care intervention in a population with a high prevalence of people living with HIV. BMC Public Health. 2011;11:828.
Chibanda D, Verhey R, Gibson LJ, Munetsi E, Machando D, Rusakaniko S, Munjoma R, Araya R, Weiss HA, Abas M. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe. J Affect Disord. 2016;198:50–5.
Andrews G, Slade T, Peters L. Classification in psychiatry: ICD-10 versus DSM-IV. Br J Psychiatry. 1999;174:3–5.
Breedlove G, Fryzelka D. Depression screening during pregnancy. J Midwifery Womens Health. 2011;56(1):18–25.
Witting MD, Furuno JP, Hirshon JM, Krugman SD, Perisse AR, Limcangco R. Support for emergency department screening for intimate partner violence depends on perceived risk. J Interpers Violence. 2006;21(5):585–96.
Bernard C, Dabis F, de Rekeneire N. Prevalence and factors associated with depression in people living with HIV in sub-Saharan Africa: a systematic review and meta-analysis. PLoS One. 2017;12(8):e0181960.
Trabold N, McMahon J, Alsobrooks S, Whitney S, Mittal M. A systematic review of intimate partner violence interventions: state of the field and implications for practitioners. Trauma Violence Abuse. 2018:1524838018767934.
The authors would like to acknowledge all the participants in the study and the nursing staff in the four study clinics of Chitungwiza for facilitating this study by providing space at the local clinics and logistical support to carry out the study.
The last author DC is supported through the DELTAS Africa Initiative [DEL-15-01]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)‘s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa’s Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [DEL-15-01] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, WellcomeTrust or the UK government. The funder was not involved in any aspect of this study.
Availability of data and materials
The dataset supporting the findings of this study can be made available upon request to the first author whose email is email@example.com.
Ethics approval and consent to participate
This study received ethics approval by the Medical Research Council of Zimbabwe (MRCZ) and all participants gave written informed consent to participate in the study.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.